Life Sciences Health Industry China Briefing


Life Sciences Health Industry China Briefing summarizes the business, regulatory and legal developments during June 2011 in China important for drug, device, and life science/health care companies


Tianjin Pharma Firm to Build Base in US (Global Times 2011-06-03) - June 3, 2011

Tianjin-based pharmaceutical company Tasly Group is investing $40 million to build a production and training center in Maryland to help prepare for the entry of its Compound Danshen Dripping Pills (CDDP) into the American market, the company announced in Shanghai on Thursday. The 430,000 sq. ft. facility is expected to be complete within a year-and-a-half, and will serve as a base for further clinical trials of CDDP, as well as its future production, packaging and warehousing.

Media Forces Drug Firm to Act (Shanghai Daily 2011-06-09) - June 9, 2011

Media exposure of environmental contamination has forced Harbin Pharmaceutical Group Co. to reduce or even stop production until the company takes steps to solve the problem. The drug-maker admitted in a statement to the Shanghai Stock Exchange that it has "problems" in discharging waste water and incineration of industrial wastes. It agreed to cut back on production until its water processing system, which has been under repair since March, becomes operational in the middle of this month.

Please see full alert below for more information.

LOADING PDF: If there are any problems, click here to download the file.